Drug delivery technique makes cancer immunotherapy more effective
Researchers in the Institute for Molecular Engineering at the University of Chicago (IME) have developed a new way to target immunotherapies and deliver them directly to tumors.
A band of scientists
Science is their life's work. Music is a lifelong passion. After hours, these University of Chicago researchers and physicians turn their creative energies to the stage.
Clinical trial, team approach help breast cancer patient survive and thrive
When Michele Kerulis was diagnosed with breast cancer, she turned to UChicago Medicine experts for help. Rita Nanda, MD, offered Kerulis participation in a clinical trial testing the addition of an immunotherapy to standard chemotherapy for high-risk breast cancers. The cancer went into remission.
